Latest BeiGene Ltd. American Depositary Shares (ONC) News on February 22, 2025
Investor's Business Daily
19 hours ago
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
MT Newswires
a day ago
BeiGene Insider Sold Shares Worth $12,485,045, According to a Recent SEC Filing
Business Wire
9 days ago
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
Simply Wall St.
10 days ago
Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:ONC) 41% Undervaluation?
MT Newswires
16 days ago
Beigene Insider Sold Shares Worth $9,424,955, According to a Recent SEC Filing
Clinical Trials Arena
23 days ago
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo
MT Newswires
24 days ago
ImmunityBio Partners With BeiGene to Conduct Phase 3 Trial of Lung Cancer Combination Therapy
Simply Wall St.
a month ago
Discover 3 US Stocks Including Microchip Technology That May Be Trading Below Estimated Fair Value
MT Newswires
a month ago
Beigene Insider Sold Shares Worth $7,370,515, According to a Recent SEC Filing
